FDA

News

FDA seeks feedback on digital tools for diabetes

The FDA has opened a comment period, extending until the end of the month, that is seeking information on how digital health technologies (DHTs) might be deployed to help

News

FDA finds no link between GLP-1 drugs and suicide

The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide, saying it can find no evid

News

FDA blocks Astellas’ Claudin cancer drug over manufacturing

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug can

Views & Analysis

JPM: Four ways FDA is seeking to buoy gene therapy

On the outskirts of the JP Morgan Healthcare Conference today, FDA's Dr Peter Marks discussed how to get more gene therapies approved in 2024.

News

Florida is first US state cleared to import Canadian drugs

The FDA has approved the first request from a US state to import prescription medicines from Canada, giving the green light to Florida for a programme that aims to reduce

News